Tag: BCMA-CD3 bispecific antibody

Home / BCMA-CD3 bispecific antibody

Categories

Elranatamab-bcmm receives accelerated approval by FDA for multiple myeloma

Nov 2023: Elranatamab-bcmm (Elrexfio, Pfizer, Inc.) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager that was given accelerated approval by the Food and Drug Administratio...
bcma-cd3-bispecific-antibody

Scan the code